1989 г. – the medicine Mifegyne (mifepristone) was registered in France with an indication – medical abortion up to 49 day of amenorrhea
Mifegyne – original product by the French company Еxelgyn
Mifegyne – the only mifepristone with four indications:
- medical abortion up to 63 day of amenorrhea in combination with prostaglandin
- preparation for surgical abortion
- abortion due to medical indications in the second trimester in combination with prostaglandins
- expulsion of a dead foetus
Mifegyne is presently registered in more than 30 countries in the world, with 30-90% of women in the developed European countries choosing this elegant method of pregnancy termination over the surgical one.
The medical method does not increase the frequency of abortions, but rather decreases the gestation week in which women terminate the pregnancy as well as the psychological trauma of the procedure.
In interviews women do not mention the medical abortion they have experienced, as it resembles the natural menstruation thus leaving no negative trace in their minds.
For more information: www.prekasvanenabremennostta.bg